Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?

@article{Wilkinson2003MedicinalCI,
  title={Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects?},
  author={J. D. Wilkinson and Benjamin J. Whalley and D. Baker and G. Pryce and A. Constanti and S. Gibbons and Elizabeth Williamson},
  journal={Journal of Pharmacy and Pharmacology},
  year={2003},
  volume={55}
}
  • J. D. Wilkinson, Benjamin J. Whalley, +4 authors Elizabeth Williamson
  • Published 2003
  • Medicine
  • Journal of Pharmacy and Pharmacology
  • Cannabis is under clinical investigation to assess its potential for medicinal use, but the question arises as to whether there is any advantage in using cannabis extracts compared with isolated Δ9‐trans‐tetrahydrocannabinol (Δ9THC), the major psychoactive component. We have compared the effect of a standardized cannabis extract (SCE) with pure Δ9THC, at matched concentrations of Δ9THC, and also with a Δ9THC‐free extract (Δ9THC‐free SCE), using two cannabinoid‐sensitive models, a mouse model of… CONTINUE READING
    68 Citations
    Phytocannabinoids as novel therapeutic agents in CNS disorders.
    • 200
    • PDF
    Cannabis sativa and the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
    • 25
    • PDF
    Development of cannabidiol as a treatment for severe childhood epilepsies
    • PDF
    Cannabinoid-Based Medicines for Neurological Disorders—Clinical Evidence
    • 23

    References

    SHOWING 1-10 OF 62 REFERENCES
    Molecular characterization of a peripheral receptor for cannabinoids
    • 4,243
    ACTIVITY OF CANNABIS IN RELATION TO ITS Δ‘‐trans‐TETRAHYDROCANNABINOL CONTENT
    • 33
    • PDF
    Therapeutic Potential of Cannabinoids in CNS Disease
    • 214
    • PDF
    Pharmacokinetics and Pharmacodynamics of Cannabinoids
    • 832
    • PDF
    Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
    • 762
    • PDF
    Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.
    • 190
    • PDF
    Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans
    • 131
    Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
    • 197
    • PDF
    Endocannabinoids control spasticity in a multiple sclerosis model
    • D. Baker, G. Pryce, +8 authors V. Marzo
    • Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 2001
    • 371
    • PDF